Pegolo G, Buckwalter J G, Weiss M H, Hinton D R
Department of Pathology, University of Southern California, Los Angeles, USA.
Acta Cytol. 1995 Sep-Oct;39(5):887-92.
To determine the extent of nuclear pleomorphism in pituitary adenomas and the relationship of these cytologic changes to clinical features, endocrine evaluations and proliferative potential.
The study group consisted of 93 sequential patients with pituitary adenomas in which smear and touch preparations were performed. Nuclear pleomorphism was assessed semiquantitatively and compared to immunohistochemical analyses of pituitary hormones on formalin-fixed paraffin sections, endocrine evaluations, clinical observations and proliferative potential as determined by immunoreactivity to Ki-67 on frozen sections.
Varying degrees of nuclear pleomorphism were observed in 66/93 tumors. However, these changes were more pronounced in clinically functioning (growth hormone, prolactin or ACTH), as compared to nonfunctioning, tumors (P < .01). Pleomorphism did not correlate with macroscopic invasiveness. The pituitary adenomas that showed pleomorphism had significantly higher Ki-67 indices than did those without nuclear changes (P < .02). Significantly higher Ki-67 expression was also found in clinically functioning tumors when compared to nonfunctioning tumors (P < .03).
Significant nuclear pleomorphism is common in functional pituitary adenomas of several types but does not correlate with more aggressive behavior.
确定垂体腺瘤中核异型性的程度,以及这些细胞学变化与临床特征、内分泌评估和增殖潜能之间的关系。
研究组由93例连续的垂体腺瘤患者组成,对其进行涂片和触片制备。对核异型性进行半定量评估,并与福尔马林固定石蜡切片上垂体激素的免疫组化分析、内分泌评估、临床观察以及冷冻切片上Ki-67免疫反应性所确定的增殖潜能进行比较。
在93例肿瘤中有66例观察到不同程度的核异型性。然而,与无功能肿瘤相比,这些变化在有临床功能的(生长激素、催乳素或促肾上腺皮质激素)肿瘤中更为明显(P < 0.01)。异型性与宏观侵袭性无关。显示异型性的垂体腺瘤的Ki-67指数显著高于无核变化的腺瘤(P < 0.02)。与无功能肿瘤相比,有临床功能的肿瘤中Ki-67表达也显著更高(P < 0.03)。
显著的核异型性在几种类型的功能性垂体腺瘤中很常见,但与侵袭性更强的行为无关。